低危甲状腺乳头状癌腺叶切除后血清甲状腺球蛋白水平变化
该历史队列研究纳入208例低危甲状腺乳头状癌行腺叶切除且无需激素替代的患者,随访中位6.9年。血清Tg水平逐渐升高,Tg/TSH比值亦升高,但复发与未复发患者间无显著差异,提示定期监测Tg对预测复发似价值有限。
要点
- 低危PTC腺叶切除后,血清Tg及Tg/TSH比值随时间逐渐升高。
- 复发与未复发患者的Tg及Tg/TSH比值变化无显著差异。
- 定期监测血清Tg对预测腺叶切除后复发似价值有限。
核心结论
- 低危PTC患者腺叶切除后,无论是否复发,血清Tg及Tg/TSH比值均逐渐升高且无显著差异,定期监测Tg对预测复发似价值有限。
研究设计与样本
- 历史队列研究,纳入208例低危PTC行腺叶切除且无需激素替代的患者,随访中位6.9年,评估术后血清Tg、Tg/TSH比值及颈部超声。
主要发现
- 血清Tg水平逐渐升高,随访6年间Tg>10 ng/dL的患者比例每年增加13.9%、18.8%、22.1%、21.9%、28.4%、28.9%(β=0.574,p=0.027)。
- 相对血清Tg水平每年增加10%(β=0.105,p<0.001)。
- 19例复发患者的Tg及Tg/TSH比值与未复发者无显著差异(β=0.150,p=0.090)。
- 无复发患者更可能出现血清Tg升高>20%(p=0.022)。
- 血清Tg升高≥50%或≥100%的患者比例在复发与否间无显著差异。
临床怎么用
- 低危PTC腺叶切除后,血清Tg及Tg/TSH比值会逐渐升高,定期监测Tg对预测复发的价值似乎有限。
局限性
- 原文未述局限性
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Low-risk patients with differentiated thyroid cancer can be treated with thyroid lobectomy. Serial measurements of serum thyroglobulin (Tg) are recommended for surveillance, but the cutoff values indicating recurrence are not known. This study documented the natural course of serum Tg levels during follow-up after lobectomy for low-risk papillary thyroid carcinoma (PTC) and evaluated whether changes in serum Tg levels predict disease recurrence. METHODS: This historical cohort study included 208 patients with low-risk PTC who underwent lobectomy but did not require hormone replacement. Postoperative serum Tg levels and Tg/thyrotropin (TSH) ratios and neck ultrasound were evaluated during a follow-up period with a median of 6.9 years. RESULTS: The serum Tg levels increased gradually, and the proportion of patients with levels >10 ng/dL increased annually by 13.9%, 18.8%, 22.1%, 21.9%, 28.4%, and 28.9% during the six-year follow-up period (β = 0.574, p = 0.027). The relative serum Tg levels increased by 10% annually (β = 0.105, p < 0.001), and the levels of Tg and Tg/TSH ratios in 19 patients with recurrent disease did not differ significantly (β = 0.150, p = 0.090). Patients without recurrent disease were more likely to have serum Tg levels increased by >20% (p = 0.022). There were no significant differences in the proportions of patients with serum Tg levels increased by ≥50% or ≥100% in terms of the disease recurrence. CONCLUSIONS: Serum Tg levels and the Tg/TSH ratio increased gradually after lobectomy in patients with and without recurrences, without any significant differences. Periodic measurements of serum Tg levels seem to have limited value in predicting recurrent PTCs after lobectomy.
引用
- Park S, Jeon MJ, Oh HS, et al. Changes in Serum Thyroglobulin Levels After Lobectomy in Patients with Low-Risk Papillary Thyroid Cancer. Thyroid. 2018. PMID: 29845894. doi:10.1089/thy.2018.0046
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。